Data / Form D filings / Deep Blue Medical Advances, Inc.
Deep Blue Medical Advances, Inc.: Form D filings
Deep Blue Medical Advances, Inc., a biotechnology company in Durham, NC, filed 6 Form D notices with the SEC between 2018 and 2025. The latest, on September 22, 2025, reports $5.3 million sold of a $5.7 million offering to 105 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 701 W. Main St, Suite 410, Durham, NC, 27701
- Phone
- (408) 242-9323
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1726572
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | New notice | $5,650,000 | $5,261,533 | $388,467 | 105 | Sep 9, 2025 | sec.gov |
| Jun 30, 2022 | New notice | $7,500,000 | $7,033,711 | $466,289 | 113 | Jun 21, 2022 | sec.gov |
| Feb 3, 2021 | New notice | $3,523,734 | $3,443,506 | $80,228 | 106 | Jun 27, 2019 | sec.gov |
| Jan 28, 2021 | New notice | $1,600,000 | $1,574,163 | $25,837 | 73 | Dec 9, 2020 | sec.gov |
| Aug 30, 2018 | New notice | $295,000 | $295,000 | 18 | Jul 5, 2018 | sec.gov | |
| Jan 24, 2018 | New notice | $800,000 | $517,000 | $283,000 | 18 | Dec 8, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Howard Levinson | Executive Officer, Director | |
| William Perry | Executive Officer, Director | |
| Michael Bates | Director | |
| Neil Meyer | Director | |
| Brent Duncan | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Sep 22, 2025 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Deep Blue Medical Advances, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.